Insights That Power
Better Prescribing

The DRIPBaR Grand Forks struggled with time-consuming, manual prescription management as patient demand for IV therapy and wellness services grew. After adopting BoomRx, the clinic centralized ordering, reduced administrative workload by over 90%, and improved efficiency, allowing providers to focus more on patient care and expansion.

Today’s patients expect more from their skincare—better results, smarter solutions, and products that deliver. Introducing BoomRx’s advanced peptides featuring Copper Peptide Skin Repair Cream, a powerful formula that supports smoother texture, improved firmness, and the appearance of youthful, collagen-rich skin.

BoomRx has launched a peptide-based skincare line centered on GHK-Cu (Copper Tripeptide-1), helping practices tap into one of the fastest-growing trends in skincare. The new portfolio begins with Copper Peptide Skin Repair Cream, debuting at A4M’s Longevity SpringFest 2026.

Peptide therapies are expanding fast across weight loss, hormone health, and performance medicine — and provider demand is outpacing compliant supply. BoomRx breaks down what's driving the surge, where the sourcing risks are, and how a single portal is helping practices keep up without cutting corners.

BoomRx’s platform consolidates access to products from both 503A compounding pharmacies and FDA-registered 503B outsourcing facilities.

Prescription fulfillment is now a core part of patient care, but fragmented pharmacy sourcing creates delays, errors, and staff overload. BoomRx centralizes pharmacy access, streamlines workflows, and ensures consistent, reliable fulfillment—so clinics can grow without compromising care.

FDA restrictions pushed peptide demand into unsafe gray markets. BoomRx stresses that patient safety relies on regulated supply chains, not access limits. The lesson: meet demand within regulated systems to prevent unsafe alternatives.

BoomRx is expanding access to peptide therapies through its centralized portal, helping medical practices simplify sourcing and fulfillment. By consolidating workflows into one platform, it enables scalable, compliant care programs with less administrative complexity.

BoomRx has generated more than $15.5 million in revenue since launching in July 2025, now serving 1,750+ clinics and processing over 8,000 orders per month. The platform streamlines prescription sourcing by connecting clinics directly to a national pharmacy network.

Most medical clinics are dragging an anchor when it comes to prescription sourcing and fulfillment—and don't even know it. Two pharmacies. Three. Sometimes four. Just to fill one patient's order. That anchor has a price. And it is bigger than you think. This explainer video shows you how BoomRx cuts that anchor loose.

Featured in Investors Hangout, BoomRx announced an oral, nanoemulsion-based liquid testosterone therapy that removes the need for injections and supports telehealth, clinic, and med spa expansion. The platform also streamlines multi-pharmacy ordering and nationwide fulfillment to modernize TRT delivery.

BoomRx addresses one of clinics’ biggest operational frustrations, vendor silence, by making proactive, transparent communication a core part of its prescription fulfillment infrastructure, helping practices prevent disruptions, plan confidently, and protect the patient experience

BoomRx has launched an injection-free oral liquid testosterone therapy using nanoemulsion delivery, designed to help telemedicine, med spas, and hybrid practices expand TRT services without the operational burden of in-office injections.

BoomRx has launched a new oral liquid erectile dysfunction therapy that combines sildenafil, tadalafil, and vardenafil in a nanoemulsion delivery system, giving healthcare providers a more flexible, injection-free option to support men’s sexual health as part of comprehensive wellness care.

Short-term prescription spikes are manageable, but sustained demand exposes whether a clinic’s sourcing, fulfillment, and operational infrastructure is truly built to scale or destined to break under pressure.

BoomRx today announced the availability of oral semaglutide and tirzepatide options using advanced nanoemulsion delivery for medical clinics, med spas, wellness practices, and telemedicine providers nationwide.

In 2026, the question is no longer whether unified platforms will replace fragmented vendors. The question is how long clinics can afford to operate without one.

A Tampa-based pharmaceutical technology platform is aiming to fix one of the most persistent challenges for medical clinics, med spas and telehealth providers: pharmacy fulfillment.

BoomRX’s platform includes real-time order tracking, automated SMS delivery updates for patients and centralized reporting for clinics.